CD22+ Relapsed/Refractory B-ALL
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB18801 | Yttrium Y-90 epratuzumab tetraxetan | 2 | Withdrawn | 1 |
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB18801 | Yttrium Y-90 epratuzumab tetraxetan | 2 | Withdrawn | 1 |